Antimicrobial resistance remains a major threat to global public health, with increasing reports of the spread of β-lactamase genes posing significant risks. The number of Enterobacteriaceae harboring plasmid-mediated AmpC enzymes has been rising worldwide, with prevalence rates varying across regions. These β-lactamases are of particular epidemiological concern because they confer resistance to several β-lactam antibiotics, including penicillins, second and third-generation cephalosporins, and monobactams, while isolates typically remain susceptible to cefepime and carbapenems. This study reports, for the first time in Brazil, the detection of the blaACT-5 gene in a Klebsiella pneumoniae isolate recovered from a community-acquired infection clinical sample in Rio de Janeiro, which notably exhibited resistance to both cefepime and carbapenems.
Rodríguez-GuerreroE, Callejas-RodelasJC, Navarro-MaríJM, et al.Systematic review of plasmid AmpC type resistances in escherichia coli and klebsiella pneumoniae and preliminary proposal of a simplified screening method for ampC. Microorganisms, 2022; 10(3):611; doi: 10.3390/microorganisms10030611
2.
MohamedES, KhairyRMM, AbdelrahimSS. Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing enterobacteriaceae strains isolated from UTIs in Egypt. Antimicrob Resist Infect Control, 2020; 9(1):198; doi: 10.1186/s13756-020-00856-w
3.
MeloLC, OrescoC, LeigueL, et al.Prevalence and molecular features of ESBL/pAmpC-producing enterobacteriaceae in healthy and diseased companion animals in Brazil. Vet Microbiol, 2018; 221:59–66; doi: 10.1016/j.vetmic.2018.05.017
4.
TepeliSÖ, Demirel ZorbaNN. Frequency of extended-spectrum β-lactamase (ESBL)—and AmpC β-lactamase–producing enterobacteriaceae in a cheese production process. J Dairy Sci, 2018; 101(4):2906–2914; doi: 10.3168/jds.2017-13878
5.
PetitM, BidarF, FosseQ, et al.Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing enterobacterales in critically ill patients: A prospective multicenter observational study. Crit Care, 2024; 28(1):40; doi: 10.1186/s13054-024-04820-7
6.
TammaPD, DoiY, BonomoRA, et al.; Antibacterial Resistance Leadership Group. A primer on AmpC β-lactamases: Necessary knowledge for an increasingly multidrug-resistant world. Clin Infect Dis, 2019; 69(8):1446–1455; doi: 10.1093/cid/ciz173
RussD, GlaserF, Shaer TamarE, et al.Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor. Nat Commun, 2020; 11(1):2029; doi: 10.1038/s41467-020-15666-2
9.
AkataK, MurataniT, YateraK, et al.Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in enterobacteriaceae. PLoS One, 2019; 14(7):e0218589; doi: 10.1371/journal.pone.0218589
10.
PaiH, KangC-I, ByeonJ-H, et al.Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing klebsiella pneumoniae. Antimicrob Agents Chemother, 2004; 48(10):3720–3728; doi: 10.1128/AAC.48.10.3720-3728.2004
11.
Rodríguez-BañoJ, Gutiérrez-GutiérrezB, MachucaI, PascualA. Treatment of infections caused by extended-spectrum-Β-lactamase, AmpC−, and carbapenemase-producing enterobacteriaceae. Clin Microbiol Rev, 2018; 31(2):e00079–e00017; doi: 10.1128/CMR.00079-17
12.
HanB, FengC, JiangY, et al.Mobile genetic elements encoding antibiotic resistance genes and virulence genes in klebsiella pneumoniae: Important pathways for the acquisition of virulence and resistance. Front Microbiol, 2025; 16:1529157; doi: 10.3389/fmicb.2025.1529157
13.
Navon-VeneziaS, KondratyevaK, CarattoliA. Klebsiella pneumoniae: A major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev, 2017; 41(3):252–275; doi: 10.1093/femsre/fux013
14.
SongW, JeongSH, KimJ-S, et al.Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of klebsiella spp., salmonella spp., and proteus mirabilis. Diagn Microbiol Infect Dis, 2007; 57(3):315–318; doi: 10.1016/j.diagmicrobio.2006.08.023
15.
EUCAST. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. EUCAST; 2017.
16.
Pérez-PérezFJ, HansonND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol, 2002; 40(6):2153–2162; doi: 10.1128/jcm.40.6.2153-2162.2002
